PORTUGAL - Riverside acquires Crioestaminal

The transaction was carried out via Riverside Europe Fund IV, with financing provided by Banco Espírito Santo Millenium Banco Comercial Português.

Based in Cantanhede, Crioestaminal was established in 2003 as a biotechnology company specialising on the isolation and cryopreservation of stem cells from umbilical cord blood.

The company is the third-largest player in Europe in number of samples stored. It has had a presence in Italy through Hematos since 2006, and in Spain where it established a subsidiary with its own sales force, starting operations in April 2008.

Riverside typically invests in SMEs with a value of up to EUR 150m.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Southern Europe